Further experiments revealed that hyperglycemia-induced PARP1 promotes diabetic neointimal hyperplasia via down-regulating TFPI-2 (which normally suppresses proliferation of vascular smooth muscle cells). The gene discussed is PARP1; the disease is Hyperglycemia.